Acadian Asset Management
ANIX icon

Acadian Asset Management’s Anixa Biosciences ANIX Stock Holding History

Acadian Asset Management’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,898
Closed -$33K – 1987
2026
Q1 		$33K Sell
12,898
-31,403
-71% -$93K ﹤0.01% 1899
2025
Q4 		$136K Buy
44,301
+23,526
+113% +$96.3K ﹤0.01% 1607
2025
Q3 		$66K Buy
+20,775
New +$65.7K ﹤0.01% 1600
2022
Q3 		– Sell
-8,675
Closed -$27K – 1663
2022
Q2 		$27K Buy
+8,675
New +$27.4K ﹤0.01% 1581

Other funds holding ANIX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Acadian Asset Management's ANIX Position: Q2 2026 in Review

Acadian Asset Management sold out of Anixa Biosciences (ANIX) in Q2 2026, closing a stake of 12,898 shares — an estimated $33K sold.

Acadian Asset Management first reported a position in ANIX in Q2 2022 and held it in 4 quarters. The position peaked at $136K in Q4 2025. 63 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

  • Acadian Asset Management reported no remaining Anixa Biosciences position as of Q2 2026 after selling out during the quarter.
  • Acadian Asset Management sold 12,898 Anixa Biosciences shares in Q2 2026, an estimated $33K.
  • Acadian Asset Management first reported a position in Anixa Biosciences in Q2 2022 and held it in 4 quarters.
  • Acadian Asset Management's Anixa Biosciences position peaked at $136K in Q4 2025.
  • 63 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.